Skip to main content
. Author manuscript; available in PMC: 2012 Jan 24.
Published in final edited form as: Stroke. 2011 Sep 22;42(12):3551–3558. doi: 10.1161/STROKEAHA.111.627174

Figure 2.

Figure 2

BMSC treatment in T1DM-MCAO rats significantly increases BBB leakage, brain hemorrhage volume, and vascular density in the ischemic brain. A, Evans blue dye assay for BBB leakage (n=5/group). B–C, Brain hemorrhage (B) and vascular density (C) measurement. Scale bar in B and C=0.1 mm. BMSC indicates bone marrow stromal cell; T1DM, Type 1 diabetes mellitus; MCAO, middle cerebral artery occlusion; BBB, blood–brain barrier.